New Key Statistics Module, Z-Score and F-Score
NAS:AVTX Key Ratios
| Market Cap $ M | 9.99 |
| Enterprise Value $ M | 2.95 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.06 |
| Price/Sales | 0.46 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -382.19 |
| Beneish M-Score | -2.3 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 25.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.10 |
| EV-to-EBITDA | -0.11 |
| PEG | -- |
| Shares Outstanding M | 1.03 |
| Net Margin (%) | -1,638.65 |
| Operating Margin % | -1,217.82 |
| Pre-tax Margin (%) | -1,637.92 |
| Quick Ratio | 1.82 |
| Current Ratio | 1.82 |
| ROA % (ttm) | -109.45 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -98.59 |
| Dividend Yield % | -- |
| Altman Z-Score | -25.99 |
AVTX Number of Guru Trades
AVTX Volume of Guru Trades
Gurus Latest Trades with NAS:AVTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AVTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Avalo Therapeutics Inc Insider Transactions
No Available Data
News about NAS:AVTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers